Elimination of AMs by IT treatment of clodronate resulted in a significant reduction in Ki67 positive cells (0.75% ± 0.068%) compared with IV treatment (1.57% ± 0.136%), which can explain the lower tumor burden in IT‐treated group compared with IV‐treated one. Here, MKI67 is linked to neoplasm.